Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announces the following third quarter update:LinaclotideIronwood and its U.S. partner, Forest Laboratories, Inc., announced positive ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE